Dewpoint Therapeutics Appoints Joel Sendek as Chief Financial Officer
Dewpoint Therapeutics Appoints Joel Sendek as Chief Financial Officer - Sendek adds 30 years' experience in biotechnology leadership News provided by Share this article Share this article BOSTON, Feb. 11, 2021 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Joel Sendek as Chief Financial Officer and Treasurer. "As we accelerate our growth plans, Joel's financial expertise and leadership in fundraising and corporate finance for both private and public biotech companies will be invaluable," said Ameet Nathwani, M.D., Chief Executiv...